Loading clinical trials...
Loading clinical trials...
The primary objective is to compare the overall treatment effect on pain relief between icatibant and placebo. The secondary objectives are to assess the efficacy of icatibant in term of onset, extent...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sanofi
NCT07536529 · Inflammatory Joint Diseases, Rheumatoid Arthritis (RA), and more
NCT07267793 · Osteoarthritis, Knee Pain Arthritis, and more
NCT05357378 · Degenerative Joint Disease, Osteoarthritis, Hip, and more
NCT04580225 · Wrist Arthritis, Wrist Arthropathy, and more
NCT06955481 · Osteoarthritis, Knee, Joint Diseases, and more
Administrative Office
Bridgewater, New Jersey
Administrative Office
Vienna
Administrative Office
Prague
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions